TY - JOUR
T1 - Effectiveness of suicide prevention gatekeeper training for university teachers in Japan
AU - Hashimoto, Naoki
AU - Takeda, Hiroko
AU - Fujii, Yutaka
AU - Suzuki, Yuriko
AU - Kato, Takahiro A.
AU - Fujisawa, Daisuke
AU - Aoyama-Uehara, Kumi
AU - Otsuka, Kotaro
AU - Mitsui, Nobuyuki
AU - Asakura, Satoshi
AU - Kusumi, Ichiro
N1 - Funding Information:
This work was partially supported by a Grant-in-Aid for Scientific Research on The Japan Agency for Medical Research and Development (AMED) ( JP16dk0307028 to TAK). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Funding Information:
This work was partially supported by a Grant-in-Aid for Scientific Research on The Japan Agency for Medical Research and Development (AMED) (JP16dk0307028 to TAK). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.NH received personal fees from Janssen Pharmaceutical, Yoshitomiyakuhin, Otsuka Pharmaceutical, Dainippon Sumitomo Pharma, Novartis Pharma, and Meiji Seika Pharma. YF received personal fees from Yoshitomiyakuhin, Otsuka Pharmaceutical, Dainippon Sumitomo Pharma, Eisai and Meiji Seika Pharma. TAK received honoraria from Dainippon Sumitomo Pharma, Meiji Seika Pharma, MSD, Ono Pharmaceutical, Otsuka Pharmaceutical, Pfizer, Takeda Pharmaceutical, and Yoshitomiyakuhin, and received research/grant support from Otsuka Pharmaceutical, which is out of scope of the current study. DF received honoraria from Pfeizer, Terumo, MSD, Tanabe-Mitsubishi Pharma, Novo Nordisk Pharma, and Meiji Seika Pharma, and received research grant which is out of scope of the current study. KO received honoraria from Pfeizer, Dainippon Sumitomo Pharma, Mochida Pharmaceutical, Eisai, MSD, Eli Lilly, Takeda Pharmaceutical, Yoshitomiyakuhin and Kyowa Yakuhin. NM received lecture fees from Mochida Pharmaceutical. IK has received honoraria from Daiichi Sankyo, Dainippon Sumitomo Pharma, Eisai, Eli Lilly, Janssen Pharmaceutical, Lundbeck, Meiji Seika Pharma, Mochida Pharmaceutical, MSD, Mylan, Novartis Pharma, Ono Pharmaceutical, Otsuka Pharmaceutical, Pfizer, Shionogi, Shire, Taisho Toyama Pharmaceutical, Takeda Pharmaceutical, Tsumura, and Yoshitomiyakuhin, and has received research/grant support from Asahi Kasei Pharma, Astellas, Daiichi Sankyo, Dainippon Sumitomo Pharma, Eisai, Eli Lilly, Mochida Pharmaceutical, Novartis Pharma, Otsuka Pharmaceutical, Pfizer, Shionogi, Takeda Pharmaceutical and Tanabe Mitsubishi Pharma, which is out of scope of the current study.
Publisher Copyright:
© 2021
PY - 2021/6
Y1 - 2021/6
N2 - Suicide is a leading cause of death among Japanese college and university students. Our previous study showed that the gatekeeper training (GKT) program significantly improved competence and confidence in the management of suicidal students in university administrative staff. However, we could not determine which component of the program was effective, nor if this program was effective for university teachers as well. In the current study, 81 university teachers were recruited; 63 of them received a general mental health lecture (MHL) and 18 of them received a 2.5 -h GKT program based on the Mental Health First Aid program. Competence and confidence in managing suicide intervention and behavioral intention as a gatekeeper were assessed by a self-report questionnaire before and immediately after the intervention. As a result, we found a significant improvement in competence in the management of suicidal students in the GKT group compared to the MHL group. We also found significant improvements in confidence in the management of suicidal students and behavioral intention as gatekeepers in the GKT group, although the questionnaires for these outcomes were not validated. The program satisfaction score was significantly higher in the GKT group than in the MHL group. To our knowledge, this is the first study to evaluate a GKT program for university teachers in Japan. By comparing the two groups, we explicitly confirmed that active involvement of the participants is crucial for effective suicide prevention training.
AB - Suicide is a leading cause of death among Japanese college and university students. Our previous study showed that the gatekeeper training (GKT) program significantly improved competence and confidence in the management of suicidal students in university administrative staff. However, we could not determine which component of the program was effective, nor if this program was effective for university teachers as well. In the current study, 81 university teachers were recruited; 63 of them received a general mental health lecture (MHL) and 18 of them received a 2.5 -h GKT program based on the Mental Health First Aid program. Competence and confidence in managing suicide intervention and behavioral intention as a gatekeeper were assessed by a self-report questionnaire before and immediately after the intervention. As a result, we found a significant improvement in competence in the management of suicidal students in the GKT group compared to the MHL group. We also found significant improvements in confidence in the management of suicidal students and behavioral intention as gatekeepers in the GKT group, although the questionnaires for these outcomes were not validated. The program satisfaction score was significantly higher in the GKT group than in the MHL group. To our knowledge, this is the first study to evaluate a GKT program for university teachers in Japan. By comparing the two groups, we explicitly confirmed that active involvement of the participants is crucial for effective suicide prevention training.
KW - College student
KW - Gatekeeper
KW - Intervention
KW - Mental health first aid
KW - Suicide
UR - http://www.scopus.com/inward/record.url?scp=85107088811&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85107088811&partnerID=8YFLogxK
U2 - 10.1016/j.ajp.2021.102661
DO - 10.1016/j.ajp.2021.102661
M3 - Article
C2 - 33932765
AN - SCOPUS:85107088811
VL - 60
JO - Asian Journal of Psychiatry
JF - Asian Journal of Psychiatry
SN - 1876-2018
M1 - 102661
ER -